Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
US10265267B2 · kind B2 · utility
0Cited by
172References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2018 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Feb 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M11/005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.